New eye drops aim to soothe dry eye sufferers
NCT ID NCT06780306
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new eye treatment called TTAX03 in 74 people with mild to moderate dry eye disease. The goal was to see if it is safe and if it can reduce eye dryness and damage. Participants received either a single dose of TTAX03 or a saline (salt water) control and were checked over 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Research, LLC.
Deerfield Beach, Florida, 33064, United States
-
CORE, Inc. / Vita Eye Clinic
Shelby, North Carolina, 28150, United States
-
Eye Associates of North Jersey
Dover, New Jersey, 07801, United States
-
Northern New Jersey Eye Institute
South Orange, New Jersey, 07079, United States
-
Southwest Eye Care
Chaska, Minnesota, 55318, United States
-
University California Berkeley
Berkeley, California, 94720, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
Westlake Eye Specialists
Austin, Texas, 78749, United States
-
Wilmington Eye at Brunswick Forest
Leland, North Carolina, 28451, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can acne drug harm the eyes? new study investigates
- Which eye drop wins the dry eye battle? a Head-to-Head test
- Can a new eye drop soothe severe dry eye?
- Can a new eye drop soothe dry eye? a trial puts TRYPTYR to the test
- New imaging tools put to the test for measuring dry eye treatment effects